These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 31047270)

  • 1. Reduced Blood Serotonin Levels in Chronic Central Serous Chorioretinopathy.
    Sakai T; Tsuneoka H
    Ophthalmol Retina; 2017; 1(2):145-148. PubMed ID: 31047270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central Serous Chorioretinopathy and Blood Serotonin Concentrations.
    Kimura T; Araki T; Komuku Y; Iwami H; Gomi F
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33546112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An association between central serous chorioretinopathy and gastroesophageal reflux disease.
    Mansuetta CC; Mason JO; Swanner J; Feist RM; White MF; Thomley ML; McGwin G; Emond TL
    Am J Ophthalmol; 2004 Jun; 137(6):1096-100. PubMed ID: 15183795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels.
    Çiloğlu E; Unal F; Dogan NC
    Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1111-1116. PubMed ID: 29671064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular pigment optical density in central serous chorioretinopathy.
    Sasamoto Y; Gomi F; Sawa M; Tsujikawa M; Hamasaki T
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5219-25. PubMed ID: 20445108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Half-time photodynamic therapy in treatment of chronic central serous chorioretinopathy.
    Sheptulin V; Purtskhvanidze K; Roider J
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2027-2034. PubMed ID: 30097783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial DNA as a Biomarker for Acute Central Serous Chorioretinopathy: A Case-Control Study.
    Hashida N; Asao K; Hara C; Quantock AJ; Saita R; Kurakami H; Maruyama K; Nishida K
    Front Med (Lausanne); 2022; 9():938600. PubMed ID: 35801206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Central Serous Chorioretinopathy with Psychosocial Factors is Dependent on Its Phase and Subtype.
    Kim YK; Woo SJ; Park KH; Chi YK; Han JW; Kim KW
    Korean J Ophthalmol; 2018 Aug; 32(4):281-289. PubMed ID: 30091306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the tissue-type plasminogen activator -7351C > T and plasminogen activator inhibitor 1 4G/5G gene polymorphisms in central serous chorioretinopathy.
    Malle EM; Posch-Pertl L; Renner W; Pinter-Hausberger S; Singer C; Haas A; Wedrich A; Weger M
    Ophthalmic Genet; 2018 Dec; 39(6):714-716. PubMed ID: 30442055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological factors associated with acute and chronic central serous chorioretinopathy.
    Lahousen T; Painold A; Luxenberger W; Schienle A; Kapfhammer HP; Ille R
    Nord J Psychiatry; 2016; 70(1):24-30. PubMed ID: 25947110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine levels of the aqueous humour in central serous chorioretinopathy.
    Jung SH; Kim KA; Sohn SW; Yang SJ
    Clin Exp Optom; 2014 May; 97(3):264-9. PubMed ID: 24417755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CLASSIFICATION OF HALLER VESSEL ARRANGEMENTS IN ACUTE AND CHRONIC CENTRAL SEROUS CHORIORETINOPATHY IMAGED WITH EN FACE OPTICAL COHERENCE TOMOGRAPHY.
    Savastano MC; Dansingani KK; Rispoli M; Virgili G; Savastano A; Freund KB; Lumbroso B
    Retina; 2018 Jun; 38(6):1211-1215. PubMed ID: 28489695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential diagnostic OCT-criteria of acute and chronic central serous chorioretinopathy].
    Doga AV; Klepinina OB; Pedanova EK; Mushkova IA
    Vestn Oftalmol; 2017; 133(6):10-15. PubMed ID: 29319664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and correlation of stress scores with blood pressure, endogenous cortisol levels, and homocysteine levels in patients with central serous chorioretinopathy and comparison with age-matched controls.
    Agarwal A; Garg M; Dixit N; Godara R
    Indian J Ophthalmol; 2016 Nov; 64(11):803-805. PubMed ID: 27958201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional configuration of subretinal fluid in central serous chorioretinopathy.
    Ahn SE; Oh J; Oh JH; Oh IK; Kim SW; Huh K
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):5944-52. PubMed ID: 23920371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging.
    Balaratnasingam C; Freund KB; Tan AM; Mrejen S; Hunyor AP; Keegan DJ; Dansingani KK; Dayani PN; Barbazetto IA; Sarraf D; Jampol LM; Yannuzzi LA
    Ophthalmology; 2016 Jul; 123(7):1541-52. PubMed ID: 27084564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
    Matušková V; Vysloužilová D; Uher M
    Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of glaucoma in central serous chorioretinopathy: a case-control study.
    Imamura Y; Fujiwara T; Spaide RF
    Retina; 2010 Feb; 30(2):267-70. PubMed ID: 19996820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy.
    Cakir B; Fischer F; Ehlken C; Bühler A; Stahl A; Schlunck G; Böhringer D; Agostini H; Lange C
    Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2151-2157. PubMed ID: 27145785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.
    Kitzmann AS; Pulido JS; Diehl NN; Hodge DO; Burke JP
    Ophthalmology; 2008 Jan; 115(1):169-73. PubMed ID: 18166410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.